News | June 22, 2022

Rockwell Automation And Cytiva Collaborate To Digitalize Operations At Innovative Pharmaceutical Development Center

Source: Cytiva
Testa-Center-Cytiva-5753

Brussels - Rockwell Automation, the world’s largest company dedicated to industrial automation and digital transformation, announced that its advanced digitalized life sciences production solutions are playing a key role in an innovative pharmaceutical development center in Uppsala, Sweden.

The Testa Center – an initiative between the Swedish government and Cytiva, a global life sciences leader – was created in 2018 to support the growth of the Life Sciences industry and its manufacturing capabilities. Since 2019, it has served to strengthen the longstanding relationship between Rockwell and Cytiva and their collaboration on automation within the biomanufacturing industry.

Rockwell Automation and Cytiva bring their expertise in biomanufacturing and automation to the center to create an efficient, flexible, and scalable platform designed to illustrate, prove, and accelerate the industry’s digital transformation. The collaboration enables stronger integration, data collection, and analysis, resulting in a standardized manufacturing platform capable of core data management.

Åsa Arvidsson, Vice President EMEA North region at Rockwell Automation, explains: “Adaptability and scalability are essential facets of any contemporary life sciences operation. As personalized treatments, single-use skids, and rapid-development programs become more and more common, manufacturers need the agility to develop, test, improve, and manufacture at a pace far quicker than ever before. This can only be achieved efficiently with digitalized process and automation solutions, developed specifically with pharma needs in mind.”

Jesper Hedberg, CEO at the Testa Center, elaborates: “The center supports growth in biological, technological, and digital innovations, all of which come together to create a more agile framework for the faster, more precise, and more efficient development of personalized treatments. When we collaborate and do things together, we not only innovate quicker, but we can also make dramatic changes and improvements to help humankind.”

The collaboration, which has also seen the creation of an Automation and Digital Transformation Center, in Shanghai, is exploring how to apply the Industrial Internet of Things (IIoT), Augmented Reality (AR) and other advanced technologies for connectivity across the manufacturing process. With innovative solutions for factory field management in progress, Rockwell Automation and Cytiva are establishing a promising future for digital solutions for biopharmaceutical companies, helping enhance training and efficiency for operators, improving speed of batch review, streamlining equipment management, and intensifying efficiency.

A short video highlighting the Swedish Testa Center’s capabilities, its forward-looking vision, and the fruits of the collaboration is available here https://www.rockwellautomation.com/en-gb/company/news/presentations/innovation-in-biopharma.html

About Rockwell Automation
Rockwell Automation, Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 25,000 problem solvers dedicated to our customers in more than 100 countries. To learn more about how we are bringing The Connected Enterprise to life across industrial enterprises, visit www.rockwellautomation.com.

About Cytiva

Cytiva is a global life sciences leader that works with academic and translational researchers, developers and manufacturers of biotherapeutics, cell and gene therapies, and new technologies such as mRNA, to enable the delivery of transformative medicines. Cytiva is a trusted expert with nearly 10 000 associates in 40 countries dedicated to customers’ speed, flexibility, capacity and efficiency in drug discovery, research, and manufacturing.

About Testa Center

Testa Center is an initiative between the Swedish government and Cytiva to secure the growth of the life science industry and its manufacturing capabilities. The main objective is to bridge the gap from discovery to industrialization. The Testa Center has the expertise and the equipment to help teams scale up from lab bench-scale production to industrial-scale. Learn more: www.testacenter.com

Source: Cytiva